Single dose and multiple dose studies of itraconazole nanoparticles
- 1 June 2006
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 63 (2) , 95-102
- https://doi.org/10.1016/j.ejpb.2006.01.006
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Changing Strategies for the Management of Invasive Fungal InfectionsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2004
- Nebulized amphotericin B concentration and distribution in the respiratory tract of lungtransplanted patientsTransplantation, 2003
- Aspergillus infections after lung transplantation: clinical differences in type of transplant and implications for managementThe Journal of Heart and Lung Transplantation, 2003
- Recent trends in the epidemiology of invasive mycosesCurrent Opinion in Infectious Diseases, 2002
- Aerosolized amphotericin B inhalation is not effective prophylaxis of invasive aspergillus infections during prolonged neutropenia in patients after chemotherapy or autologous bone marrow transplantationEvidence-based Oncology, 2000
- Treatment strategies for Aspergillus infectionsDrug Resistance Updates, 2000
- Successful treatment of post-influenza pseudomembranous necrotising bronchial aspergillosis with liposomal amphotericin, inhaled amphotericin B, gamma interferon and GM-CSFThorax, 1999
- Pharmacokinetic Evaluation of Amphotericin B in Lung Tissue: Lung Lymph Distribution after Intravenous Injection and Airspace Distribution after Aerosolization and Inhalation of Amphotericin BAntimicrobial Agents and Chemotherapy, 1998
- Disposition of Aerosolized Liposomal Amphotericin BJournal of Pharmaceutical Sciences, 1997
- NIAID mycoses study group multicenter trial of oral itraconazole therapy for invasive aspergillosisThe American Journal of Medicine, 1994